ArticlePediatric surgery international2026
Increased chromium and molybdenum blood levels after minimally-invasive repair of pectus excavatum.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMinimally Invasive Repair of Pectus Excavatum (MIRPE) is the most popular technique to repair pectus excavatum in young patients. One or more metallic bars are inserted and maintained for at least 2-3 years. Only a few reports on possible metal release in these patients have been published. The study aimed to search for an increase in blood metal levels in patients after MIRPE and to investigate if surgical details (number of bars and stabilizers) were correlated with metal release.
methodsWe have prospectively studied blood levels of chromium, nickel, molybdenum and manganese before bar implant in a group of patients undergoing MIRPE between 2017 and 2019 and, in the same patients, at the moment of bar removals between 2020 and 2022. All our patients had the same stainless-steel bar. Blood samples were analysed using inductively coupled plasma mass spectrometry. MAIN
resultsWe included a total of 53 (10 females) patients. Median age at MIRPE was 15.4 years. After a median bar maintenance time of 3.1 years, we observed significantly higher mean levels of chromium (2.43 vs. 0.52 µg/L) and molybdenum (1.87 vs. 0.35 µg/L; p < 0.05). Nickel (4.24 vs. 80.80 µg/L) and manganese (12.69 vs. 19.81 µg/L) were also higher, although not statistically significant. No differences were found regarding the number of bars, stabilizers implanted or gender. No patients had clinical symptoms of metallosis.
conclusionsWe demonstrated that metal blood levels increase in patients with retrosternal bars after MIRPE. Clinical implications of our finding are still unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.